Cytek Biosciences, Inc.
CTKB· Nasdaq
Released Sep 2, 2021, after the close
10-Q filed Sep 3, 2021, 65 days after period end · 0000950170-21-001668
| Metric | Q2 2021 | Q2 2020 |
|---|---|---|
| Revenue | $30.41M | $19.14M |
| Net Income | $2.67M | $8.11M |
| EPS Diluted | $0.00 | $0.06 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Cytek Biosciences, Inc. · CIK 1831915 · Engraved from SEC EDGAR
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
ended Jun 30, 2021 · filed Sep 3, 2021 · 65 d after period end
0.7% from the close of Sep 2, 2021 to the close of Sep 3, 2021, the first after the release.